BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 837646)

  • 1. Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults.
    Yacobi A; Lampman T; Levy G
    Clin Pharmacol Ther; 1977 Mar; 21(3):283-6. PubMed ID: 837646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraindividual relationships between serum protein binding of drugs in normal human subjects, patients with impaired renal function, and rats.
    Yacobi A; Levy G
    J Pharm Sci; 1977 Sep; 66(9):1285-8. PubMed ID: 333094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of coumarin anticoagulants. XIV: relationship between protein binding, distribution, and elimination kinetics of warfarin in rats.
    Yacobi A; Levy G
    J Pharm Sci; 1975 Oct; 64(10):1660-4. PubMed ID: 1195101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma protein binding of phenytoin and warfarin in patients undergoing renal transplantation.
    Odar-Cederlof I
    Clin Pharmacokinet; 1977; 2(2):147-53. PubMed ID: 324689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein binding of several drugs in serum and plasma of healthy subjects.
    Wiegand UW; Hintze KL; Slattery JT; Levy G
    Clin Pharmacol Ther; 1980 Mar; 27(3):297-300. PubMed ID: 7357788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intersubject variation of warfarin binding to protein in serum of normal subjects.
    Yacobi A; Stoll RG; DiSanto AR; Levy G
    Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):743-6. PubMed ID: 959669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrasubject variation of warfarin binding to protein in serum of patients with cardiovascular disease.
    Yacobi A; Udall JA; Levy G
    Clin Pharmacol Ther; 1976 Sep; 20(3):300-3. PubMed ID: 954352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased plasma protein binding of phenytoin in patients on valproic acid.
    Dahlqvist R; Borgå O; Rane A; Walsh Z; Sjöqvist F
    Br J Clin Pharmacol; 1979 Dec; 8(6):547-52. PubMed ID: 391256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect.
    Yacobi A; Udall JA; Levy G
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):552-8. PubMed ID: 1277711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting serum protein binding of phenytoin, diazepam and propranolol in acute renal diseases.
    Tiula E; Haapanen EJ; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):469-75. PubMed ID: 3679617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels and protein binding of phenytoin during exercise in man: the effect of elevated free fatty acids.
    Borgå O; Juhlin-Dannfeldt A; Dahlqvist R
    Pharmacology; 1978; 16(1):37-43. PubMed ID: 619360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum protein binding of phenytoin and valproic acid in insulin-dependent diabetes mellitus.
    Gatti G; Crema F; Attardo-Parrinello G; Fratino P; Aguzzi F; Perucca E
    Ther Drug Monit; 1987 Dec; 9(4):389-91. PubMed ID: 3122377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpatient and intrapatient variability in phenytoin protein binding.
    Banh HL; Burton ME; Sperling MR
    Ther Drug Monit; 2002 Jun; 24(3):379-85. PubMed ID: 12021629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin binding to human albumin.
    Lecomte M; Zini R; d'Athis P; Tillement JP
    Eur J Drug Metab Pharmacokinet; 1979; 4(1):23-8. PubMed ID: 467465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of enflurane, halothane and the halothane metabolite trifluoroacetic acid with the binding of acidic drugs to human serum albumin. An in vitro study.
    Dale O
    Biochem Pharmacol; 1986 Feb; 35(4):557-61. PubMed ID: 3947389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we routinely measure free plasma phenytoin concentration?
    Rimmer EM; Buss DC; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jan; 17(1):99-102. PubMed ID: 6419764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum protein binding of phenytoin, diazepam and propranolol in chronic renal diseases.
    Tiula E; Tallgren LG; Neuvonen PJ
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):545-52. PubMed ID: 3429058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical response in epilepsy in relation to total and free serum levels of phenytoin.
    Peterson GM; Khoo BH; von Witt RJ
    Ther Drug Monit; 1991 Sep; 13(5):415-9. PubMed ID: 1957333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of age and sex on the plasma binding of acidic and basic drugs.
    Verbeeck RK; Cardinal JA; Wallace SM
    Eur J Clin Pharmacol; 1984; 27(1):91-7. PubMed ID: 6489431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.